RecruitingNot Applicable

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

United States600 participantsStarted 2025-06-02

Plain-language summary

This is a longitudinal, observational epidemiological study designed to estimate the prevalence of depression, anxiety, and behavior problems in children ages 18 months through 11 years with cystic fibrosis (CF).

Who can participate

Age range18 Months – 11 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Child with a diagnosis of Cystic fibrosis (CF) actively followed by the CF care team at a participating site
✓. Child is age 18 months thru 11 years
✓. English and/or Spanish speaking
✓. Parent/legal guardian willing and able to give informed consent, and for minor participants ages 7 thru 11 years able to give assent.

What they're measuring

To estimate the national prevalence of depression, anxiety, and behavior problems longitudinally in early childhood (18 months - 5 years) and school-age children (6 - 11 years)

Timeframe: 07/01/2024 - 06/30/2028

Trial details

NCT IDNCT07048574

SponsorState University of New York at Buffalo

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-06

Contact for this trial

Beth A Smith, MD

716-898-5940 balucas@buffalo.edu

View on ClinicalTrials.gov More Cystic Fibrosis (CF) trials